| 抗鼻病毒抑制剂研究进展 |
| |
| 引用本文： | 于靓靓,李琳,沙浩东. 抗鼻病毒抑制剂研究进展[J]. 广州化工, 2013, 0(22): 17-19 |
| |
| 作者姓名： | 于靓靓 李琳 沙浩东 |
| |
| 作者单位： | 上海交通大学化学化工学院,上海200240 |
| |
| 摘 要： | 人鼻病毒(human rhinovirus,HRV)是一种感染性很强的病毒,是致呼吸道感染的重要致病因子。到目前为止,还没有有效地抗鼻病毒的药物上市,尽管如此,在过去的几十年里,随着对鼻病毒病理学的深入研究,鼻病毒感染过程被确定,并由此产生了许多作用于病毒复制循环过程的抗病毒药物分子,这些分子有望在未来作为治疗鼻病毒的药物。
|
| 关 键 词： | 人鼻病毒 药物 研究进展 |
Research Progress on Anti- rhinovirus Inhibitors |
| |
| Affiliation: | YU Liang - liang, LI Lin, SHA Hao - dong (Department of Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China) |
| |
| Abstract: | Human rhinovirus （HRV） is a kind of with highly infectious which is responsible for many of the severe exacerbations of asthma and chronic obstructive pulmonary disease. There is currently no antiviral drug approved for the treatment of such infections. Nevertheless, with the depth study of pathology rhinovirus, the process of rhinovirus infection was identified and a serious of antiviral compounds that inhibit the replication of the human rhinovirus were researched. As the clinical trials carry out, these molecules are expected to be the effective drugs for the treatment of rhinovirus in the future. |
| |
| Keywords: | human rhinovirus drug researching progress |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
